Denali Therapeutics Inc.

NASDAQ:DNLI

Biotechnology

Healthcare
$18.20 +0.40%

+$0.09 today

Market cap
$2.92B
Beta
1.01
P/E (TTM)
-8.7
EPS (TTM)
-$2.72
52W Low $12.58High $24.65

Volume 1.27M

Average 1.84M

Price history

Denali Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+6.06%

Period high

$27.21

Period low

$16.02

Latest

$18.20

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 3, 2026Nov 3, 2026
10-QNov 3, 2026Nov 3, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 3, 2026Sep 3, 2026
4Aug 14, 2026Aug 14, 2026
4Aug 13, 2026Aug 13, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
SC 13G/AAug 4, 2026Aug 4, 2026
8-KJul 28, 2026Jul 27, 2026
SC 13G/AJul 8, 2026Jul 8, 2026
8-KJun 18, 2026Jun 18, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026

Competitors

Who does Denali Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DNLI's filings, answered from its disclosures.

What is the latest DNLI filing?

The latest filing shown is 8-K dated Nov 3, 2026.

How many recent filings does DNLI have?

Intrinsic Alpha currently shows 20 recent filings for DNLI.